Cigna Investments’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $561K | Sell |
1,438
-105
| -7% | -$44.4K | 0.07% | 237 |
|
|
2026
Q1 | $730K | Sell |
1,543
-35
| -2% | -$17.6K | 0.11% | 166 |
|
|
2025
Q4 | $737K | Sell |
1,578
-108
| -6% | -$50.1K | 0.11% | 163 |
|
|
2025
Q3 | $719K | Sell |
1,686
-59
| -3% | -$22.9K | 0.1% | 174 |
|
|
2025
Q2 | $668K | Sell |
1,745
-115
| -6% | -$41.4K | 0.11% | 181 |
|
|
2025
Q1 | $643K | Sell |
1,860
-68
| -4% | -$21.9K | 0.12% | 178 |
|
|
2024
Q4 | $579K | Sell |
1,928
-33
| -2% | -$11.5K | 0.1% | 195 |
|
|
2024
Q3 | $797K | Sell |
1,961
-66
| -3% | -$24.2K | 0.14% | 145 |
|
|
2024
Q2 | $651K | Sell |
2,027
-71
| -3% | -$23.1K | 0.12% | 161 |
|
|
2024
Q1 | $699K | Sell |
2,098
-35
| -2% | -$10.7K | 0.13% | 162 |
|
|
2023
Q4 | $577K | Sell |
2,133
-64
| -3% | -$15.8K | 0.12% | 174 |
|
|
2023
Q3 | $541K | Sell |
2,197
-322
| -13% | -$88.1K | 0.12% | 167 |
|
|
2023
Q2 | $765K | Sell |
2,519
-106
| -4% | -$29.5K | 0.14% | 146 |
|
|
2023
Q1 | $692K | Sell |
2,625
-95
| -3% | -$24.1K | 0.14% | 152 |
|
|
2022
Q4 | $653K | Sell |
2,720
-26
| -0.9% | -$5.82K | 0.14% | 165 |
|
|
2022
Q3 | $504K | Sell |
2,746
-227
| -8% | -$45.2K | 0.11% | 189 |
|
|
2022
Q2 | $499K | Sell |
2,973
-1,319
| -31% | -$283K | 0.1% | 206 |
|
|
2022
Q1 | $1.08M | Sell |
4,292
-1,204
| -22% | -$302K | 0.13% | 151 |
|
|
2021
Q4 | $1.41M | Sell |
5,496
-2,223
| -29% | -$544K | 0.11% | 144 |
|
|
2021
Q3 | $1.87M | Sell |
7,719
-473
| -6% | -$116K | 0.14% | 132 |
|
|
2021
Q2 | $1.69M | Sell |
8,192
-1,364
| -14% | -$278K | 0.12% | 152 |
|
|
2021
Q1 | $1.8M | Buy |
9,556
+258
| +3% | +$45.5K | 0.12% | 150 |
|
|
2020
Q4 | $1.53M | Buy |
9,298
+654
| +8% | +$95.6K | 0.12% | 154 |
|
|
2020
Q3 | $1.08M | Buy |
8,644
+64
| +0.7% | +$7.92K | 0.1% | 175 |
|
|
2020
Q2 | $834K | Buy |
8,580
+1,079
| +14% | +$112K | 0.08% | 237 |
|
|
2020
Q1 | $674K | Buy |
7,501
+400
| +6% | +$51.8K | 0.09% | 248 |
|
|
2019
Q4 | $986K | Sell |
7,101
-827
| -10% | -$111K | 0.1% | 243 |
|
|
2019
Q3 | $1.06M | Buy |
7,928
+350
| +5% | +$45.2K | 0.11% | 240 |
|
|
2019
Q2 | $1.01M | Sell |
7,578
-250
| -3% | -$31.6K | 0.11% | 240 |
|
|
2019
Q1 | $1.02M | Sell |
7,828
-200
| -2% | -$26.9K | 0.11% | 227 |
|
|
2018
Q4 | $1M | Buy |
8,028
+70
| +0.9% | +$9.4K | 0.08% | 173 |
|
|
2018
Q3 | $1.06M | Sell |
7,958
-839
| -10% | -$104K | 0.09% | 179 |
|
|
2018
Q2 | $902K | Sell |
8,797
-1,644
| -16% | -$166K | 0.07% | 261 |
|
|
2018
Q1 | $1.01M | Hold |
10,441
| – | – | 0.07% | 252 |
|
|
2017
Q4 | $918K | Sell |
10,441
-670
| -6% | -$53.8K | 0.06% | 271 |
|
|
2017
Q3 | $884K | Sell |
11,111
-198
| -2% | -$15.9K | 0.06% | 286 |
|
|
2017
Q2 | $986K | Sell |
11,309
-1,884
| -14% | -$159K | 0.07% | 251 |
|
|
2017
Q1 | $1.17M | Sell |
13,193
-1,387
| -10% | -$116K | 0.08% | 233 |
|
|
2016
Q4 | $1.08M | Buy |
+14,580
| New | +$1.09M | 0.12% | 220 |
|
Other funds holding HCA
Cigna Investments's HCA Position: Q2 2026 in Review
Cigna Investments reduced its HCA Healthcare (HCA) stake by 6.8% in Q2 2026, selling an estimated $44.4K and leaving 1,438 shares worth $561K. The position accounts for 0.07% of the portfolio, ranked #237.
Cigna Investments first reported a position in HCA in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.87M in Q3 2021. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Cigna Investments held 1,438 shares of HCA Healthcare worth $561K as of Q2 2026.
- Cigna Investments sold 105 HCA Healthcare shares in Q2 2026, an estimated $44.4K.
- HCA Healthcare made up 0.07% of Cigna Investments's portfolio in Q2 2026, its #237 holding.
- Cigna Investments first reported a position in HCA Healthcare in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's HCA Healthcare position peaked at $1.87M in Q3 2021.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.